Basis of Presentation and Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Jun. 30, 2026 |
|---|
| Basis of Presentation and Summary of Significant Accounting Policies |
|
| Schedule of Inventory |
| | | | | | | | | June 30, 2026 | | September 30, 2025 | Raw materials | | $ | 2,344,459 | | $ | 2,350,239 | Work-in-process | | | 2,514,132 | | | 958,539 | Finished goods | | | 184,939 | | | 29,626 | Total | | $ | 5,043,530 | | $ | 3,338,404 |
|
| Schedule of computation of basic and diluted loss per share |
| | | | | | | | | | | | | | | | Three months ended June 30, | | Nine months ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Numerator: | | | | | | | | | | | | | Net loss attributable to common stockholders | | $ | (20,319,272) | | $ | (20,152,502) | | $ | (47,830,487) | | $ | (49,132,094) | Denominator: | | | | | | | | | | | | | Weighted average shares outstanding, basic | | | 136,743,333 | | | 36,956,582 | | | 93,232,060 | | | 30,663,988 | Basic net loss per share | | $ | (0.15) | | $ | (0.55) | | $ | (0.51) | | $ | (1.60) | Diluted net loss per share | | $ | (0.15) | | $ | (0.55) | | $ | (0.51) | | $ | (1.60) |
|
| Schedule of anti-dilutive securities |
| | | | | | | | | | | | | | | | Three months ended June 30, | | Nine months ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Performance-based stock options | | | 30,000 | | | 190,000 | | | 30,000 | | | 190,000 | Stock options | | | 6,203,902 | | | 2,822,893 | | | 6,203,902 | | | 2,822,893 | Common stock warrants | | | 40,353,913 | | | 39,811,227 | | | 40,353,913 | | | 39,811,227 | Convertible debt | | (i) | — | | (ii) | 14,702,063 | (i) | | — | | (ii) | 14,702,063 |
| (i) | The balance of the March 2025 Note (as defined in Note 7) underlying these potentially dilutive securities was fully converted during May 2026 as discussed in more detail in Note 7. |
| (ii) | In this period, the potentially dilutive securities related to the March 2025 Note were calculated based on a fixed conversion price of $2.26, which was subject to change as set forth in the March 2025 Note. |
|